The anti-depressant and anxiolytic properties of the lyophilized aqueous leaf extract of Mimosa pudica L. (Fabaceae)
Abstract
Introduction: This study seeks to determine the antidepressant and anxiolytic properties of the lyophilized aqueous leaf extract of Mimosa pudica (LAL-MP) in mice.
Methods: LAL-MP was administered orally to mice at 50 – 500 mg/kg, daily for 14 days, after which mice were individually subjected to the forced swimming (FST) and tail suspension (TST) tests, the elevated plus maze (EPM) model and locomotor activity count.
Results: Generally, LAL-MP from 100 to 500 mg/kg exhibit antidepressant and anxiolytic properties in all 4 models of depression and dose levels at 400 and 500 mg/kg were found to be equipotent with the standard drug fluoxetine.
Conclusions: This is the first report on the combined antidepressant and anxiolytic properties of LAL-MP.
Downloads
References
Ahmad, H., Sehgal, S., Mishra, A. and Gupta, R. Mimosa pudica L. (Laajvanti): an overview. Pharmacognosy Review, 2012; 6 (12): 115-124.
Bum, N.E., Dawack, D.L., Schmutz, M., Rakotonirina, S.V., Rakotonirina, S.V., Portet, C., Jeker, A. and Herrling, P. Anticonvulsant Activity of Mimosa pudica decoction. Fitoterapia, 2004; 75 (3-4): 309-314.
Molina, M., Contreras, C.M. and Tellez, A.P. Mimosa pudica may possess antidepressant actions in the rat. Phytomedicine, 1999; 6: 319-23.
Guevara, B.Q. A Guidebook to Plant Screening: Phytochemical and Biological, University of Santo Tomas, Manila, 2004.
Porsolt, R.D., Bertin, A. and Jalfre, M. Behavioral despair in mice: a primary screening test for depression. Arch. Int. Pharmacodyn. Ther. 1997; 229: 327 – 336.
Dhingra, D. and Valecha, R. Behavioral and neuroendocrene effects of aqueous extract of Boerhaavia diffusa Linn. in mice using tail suspension and forced swim tests – a preliminary study. Ind. J. Exp. Biol. 2014; 52: 53 – 59.
Shafeen, S., Reddy, S.T., Arafath, S., Nagarjuna, S. and Reddy, P.Y. Evaluation of anti-anxiety and antidepressant activity of Cassia occidentalis Leaves. Asian J. Phar. Clin. Res. 2012; 5 (3): 47 – 50.
Alagarswamy, V., Thangathiruppathy, A., Mandal, S.C., Rajasekaran, S., Revathi, V.S. Pharmacological evaluation of 2-substituted (1,3,4) thiadiazolo quinazolines. Ind. J. Pharm. Sci. 2006; 68 (1): 108 – 111.
Redmond, A.M., Kelly, G.P. and Leonard, B.E. Behavioral and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol. Biochem. Behav. 1997; 58: 355 – 359.
Pilc, A., Klodzinska, A. and Nowak, G. A role of glutamate in the treatment of anxiety and depression: focus on group 1 metabotropic gluatamate (mGlu) receptors. Drugs Future 2002; 27: 753 – 763.
Copyright (c) 2015 Research Journal of Phytomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
